Stuart M. Weiss, M.D.
NPI 1275568990ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· New York, NY
Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in New York, New York, licensed in NY, with an NPI issued in July 2006. Their prescriptions cost Medicare Part D more than their services did: $2,694,015 for 4,232 claims, against $161,468 paid for services in 2024. Novo Nordisk Inc was the largest of 18 companies reporting payments in 2025, $2,599 in all, mostly food and beverage. Lists NYU Langone Hospitals as a hospital affiliation.
Overview
| NPI | 1275568990 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Jul 11, 2006 |
| Last updated in NPPES | Jul 8, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 175583 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 409 |
|---|---|
| Services billed | 3,976 across 17 procedure codes |
| Paid by Medicare | $161,468 |
Part D prescriptions in 2024
| Prescriptions (claims) | 4,232 · 8,774 30-day fills |
|---|---|
| Patients | 353 |
| Total drug cost | $2,694,015 |
| Generic share | 39% of claims |
Education and affiliations
| Graduation year | 1985 |
|---|---|
| Medicare specialty | Endocrinology |
| Secondary specialties | Internal Medicine |
Hospital affiliation
- NYU Langone HospitalsNew York, NY
Industry payments (Open Payments)
- 2025$2,599 · 75 payments from 18 companies
- 2024$2,768 · 116 payments from 17 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $459.42 | 11 |
| Lilly USA, LLC | $453.06 | 16 |
| Beta Bionics, Inc. | $309.11 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $229.44 | 8 |
| Mannkind Corporation | $226.08 | 2 |
What the 2025 payments were for
- Food and Beverage$2,599 · 75 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in New York
- 1346562345
- 1285938381
- 1093087926
- 1417145145
- 1710128053
- 1134500762
- 1689271629
- 1841956638
- 1639895055
- 1205076890
- 1649456286
- 1396153920
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in New York →